Psychopharmacology Maastricht
The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.
Learn More
Maastricht Psychedelic Symposium
On May 24, the Maastricht Psychedelic Research Team organized a mini-symposium on psychedelics. We welcomed two international speakers: Prof. dos Santos and Prof. Bouso from Brazil and Spain to discuss their ayahuasca and ibogaine research. We also had several internal speakers: presenting on mystical vs. autobiographical psychedelic experiences (Dr Kangaslampi), microdosing (Ms. Haijen), and 5-MeO-DMT (Mr. Reckweg).
Click below to watch the entire symposium
Read about our new paper on the neurological origins of a visual psychedelic hallucination
Congratulations to Zeus Tipado on his newly published paper that introduces a new theory as to why a person experiences a visual trip on psychedelics.
Read The PaperParticipate in our studies!
We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.
View All Studies
Our Scientists
Lorena Guerra, MSc
I am Lorena, a PhD candidate from Brazil with experience working on preclinical and clinical research.
Johannes Reckweg, MSc
5-MeO-DMT, Neuropsychopharmacology, Therapy
I am Johannes, a PhD candidate from Germany. After receiving my Bachelor’s degree from the Rijksuniversiteit Groningen, I came to Maastricht for my Master in Neuropsychology.
Eline Haijen, MSc
ADHD, Microdosing, Psychedelics
I am a PhD candidate in the Psychopharmacology in Maastricht research group at the Department of Neuropsychology and Psychopharmacology at Maastricht University. I am from a little village close to Maastricht.
Dr. Peter van Ruitenbeek
My name is Dr. Peter van Ruitenbeek and I work as an assistant professor. That means I teach and do research at the faculty of psychology and neuroscience.
Katharina Lege, MSc
Cannabinoids, Neuroimaging, Consciousness
Coming from a background of psychology and clinical neuroscience, I developed a strong interest in altered states of the mind as in mediation or yoga practices.
Henry Whitfeld, MSc
Ideography, Psilocybin, Psychotherapy
After being a psychological therapist with 20years experience in trauma work and mindfulness-informed approaches, I am now a researcher investigating how psychedelic experiences and psychotherapeutic protocols interact.
Dr. Conny Quaedflieg
Stress Resilience, Intentional Forgetting, EEG
Through my extensive research experience, I have built expertise in various disciplines (psychology, psychophysiology, neurosciences) and I have become enthusiastic about bridging them.
Dr. C. Rob Markus
I became an expert on the relation between stress, brain (gene) vulnerability and the development of cognitive-affective complaints/disorders as well as in testing (claims about) dietary treatment/assessment methods.
Iva Totomanova, MSc
My primary research interest lies in exploring the potential of psychedelics to be used as novel treatment options for a range of psychiatric disorders.
Psychedelic Research
Microdosing with psychedelics to self-medicate for ADHD symptoms in adults: A prospective naturalistic study
→
Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution
Ayahuasca, ego dissolution, cognitive
→
Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking
Ayahuasca, creativity, divergent thinking, convergent thinking
→
Cannabis Research
Intoxication by a synthetic cannabinoid (JWH-018) causes cognitive and psychomotor impairment in recreational cannabis users
Cannabis, Cognition, Psychomotor
→
Medicinal Δ9-tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests
→
Comparison of Cannabinoid Pharmacokinetic Properties in Occasional and Heavy Users Smoking a Marijuana or Placebo Joint
→
Get in Touch
We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.